Jagsonpal Pharmaceuticals, 507789, JAGSNPHARM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,489.31
32.75
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,383.19
2.44%
6.47

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.16
5.71
11.23

EBITDA CAGR (%)

10 Years
5 Years
3 Years

25.98
18.34
20.28

PAT CAGR (%)

10 Years
5 Years
3 Years

13.77
17.96
24.25

P:E (Median)

8 Years
5 Years
3 Years

27.55
34.75
32.79

P:BV (Average)

8 Years
5 Years
3 Years

5.00
6.06
5.96

EV:EBITDA (Average)

8 Years
5 Years
3 Years

19.93
23.52
23.22

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 82.23 75.61 8.76% 64.20 58.56 9.63% 72.95 74.03 -1.46% 74.47 74.69 -0.29%
Expenses 64.99 61.40 5.85% 53.04 49.85 6.40% 56.68 58.19 -2.59% 58.03 58.41 -0.65%
EBITDA 17.24 14.21 21.32% 11.16 8.71 28.13% 16.27 15.83 2.78% 16.43 16.28 0.92%
EBIDTM 20.97% 18.80% 17.38% 14.88% 22.30% 21.39% 22.07% 21.80%
Other Income 2.83 2.83 0.00% 3.17 2.77 14.44% 2.98 2.32 28.45% 3.03 1.65 83.64%
Interest 0.25 0.25 0.00% 0.25 0.26 -3.85% 0.26 0.26 0.00% 0.27 0.23 17.39%
Depreciation 2.14 2.35 -8.94% 2.32 2.31 0.43% 2.39 2.41 -0.83% 2.39 2.34 2.14%
PBT 17.68 14.43 22.52% 11.76 8.71 35.02% 14.52 38.67 -62.45% 16.81 15.37 9.37%
Tax 4.49 3.64 23.35% 2.99 2.13 40.38% 3.57 6.68 -46.56% 4.24 3.91 8.44%
PAT 13.19 10.80 22.13% 8.76 6.58 33.13% 10.95 31.99 -65.77% 12.57 11.46 9.69%
PATM 16.04% 14.28% 13.65% 11.24% 15.01% 43.22% 16.89% 15.34%
EPS 2.00 1.64 21.95% 1.33 1.00 33.00% 1.66 4.86 -65.84% 1.91 1.74 9.77%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 293.85 287.23 268.72 208.70 236.71 217.58 187.95 158.57 166.83 126.53 143.87 Net Sales Growth 3.87% 6.89% 28.76% -11.83% 8.79% 15.76% 18.53% -4.95% 31.85% -12.05% Cost Of Goods Sold 106.08 104.37 96.43 79.98 92.34 88.96 80.78 56.19 72.85 61.11 58.95 Gross Profit 187.77 182.85 172.28 128.72 144.37 128.62 107.17 102.38 93.98 65.42 84.92 GP Margin 63.90% 63.66% 64.11% 61.68% 60.99% 59.11% 57.02% 64.56% 56.33% 51.70% 59.03% Total Expenditure 232.74 229.15 217.65 185.63 202.56 192.56 168.87 150.04 157.49 137.64 138.10 Power & Fuel Cost - 0.18 0.19 0.17 0.29 0.47 0.52 0.76 1.41 1.00 2.12 % Of Sales - 0.06% 0.07% 0.08% 0.12% 0.22% 0.28% 0.48% 0.85% 0.79% 1.47% Employee Cost - 70.74 70.93 62.09 65.18 57.67 53.98 50.37 46.61 41.88 40.95 % Of Sales - 24.63% 26.40% 29.75% 27.54% 26.51% 28.72% 31.77% 27.94% 33.10% 28.46% Manufacturing Exp. - 1.35 0.99 0.73 0.52 1.05 0.62 0.51 0.73 0.96 1.34 % Of Sales - 0.47% 0.37% 0.35% 0.22% 0.48% 0.33% 0.32% 0.44% 0.76% 0.93% General & Admin Exp. - 23.22 23.43 21.64 22.44 28.47 18.75 23.55 19.03 16.31 16.44 % Of Sales - 8.08% 8.72% 10.37% 9.48% 13.08% 9.98% 14.85% 11.41% 12.89% 11.43% Selling & Distn. Exp. - 28.25 24.87 19.16 19.21 13.88 12.99 17.45 13.20 11.25 13.74 % Of Sales - 9.84% 9.25% 9.18% 8.12% 6.38% 6.91% 11.00% 7.91% 8.89% 9.55% Miscellaneous Exp. - 1.05 0.79 1.87 2.57 2.05 1.22 1.20 3.66 5.14 13.74 % Of Sales - 0.37% 0.29% 0.90% 1.09% 0.94% 0.65% 0.76% 2.19% 4.06% 3.17% EBITDA 61.10 58.08 51.07 23.07 34.15 25.02 19.08 8.53 9.34 -11.11 5.77 EBITDA Margin 20.79% 20.22% 19.00% 11.05% 14.43% 11.50% 10.15% 5.38% 5.60% -8.78% 4.01% Other Income 12.01 11.99 8.19 9.28 5.73 3.43 4.39 2.53 1.43 0.46 0.47 Interest 1.03 1.03 0.96 0.81 0.41 0.28 0.51 0.51 0.75 0.66 2.64 Depreciation 9.24 9.44 8.13 1.66 1.21 1.53 1.09 1.13 1.02 0.32 1.99 PBT 60.77 59.60 50.17 29.87 38.27 26.64 21.87 9.41 9.00 -11.63 1.60 Tax 15.29 14.44 14.50 7.41 8.09 7.79 4.81 1.54 1.79 -0.08 2.53 Tax Rate 25.16% 25.10% 20.76% 24.81% 23.24% 29.24% 21.99% 16.37% 19.89% 0.69% 17.57% PAT 45.47 43.08 55.36 22.46 26.72 18.86 17.06 7.87 7.22 -11.55 11.86 PAT before Minority Interest 45.47 43.08 55.36 22.46 26.72 18.86 17.06 7.87 7.22 -11.55 11.86 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.47% 15.00% 20.60% 10.76% 11.29% 8.67% 9.08% 4.96% 4.33% -9.13% 8.24% PAT Growth -25.25% -22.18% 146.48% -15.94% 41.68% 10.55% 116.77% 9.00% - - EPS 6.91 6.55 8.41 3.41 4.06 2.87 2.59 1.20 1.10 -1.76 1.80

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 276.17 239.95 187.40 158.89 132.76 121.93 111.03 104.47 98.05 109.91 Share Capital 13.39 13.28 13.22 13.10 13.10 13.10 13.10 13.10 13.10 13.10 Total Reserves 242.30 204.71 157.11 137.03 119.66 108.83 97.93 91.37 84.95 96.81 Non-Current Liabilities 12.21 12.41 18.11 8.48 4.49 1.88 3.09 3.12 3.19 3.26 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.18 1.04 8.48 1.07 1.26 0.02 0.00 0.00 0.00 0.00 Current Liabilities 40.92 25.90 19.13 35.18 34.14 40.40 34.57 28.19 28.58 29.44 Trade Payables 11.58 9.73 7.60 16.58 18.55 18.05 11.71 11.86 9.09 8.98 Other Current Liabilities 14.84 15.16 10.78 10.60 7.70 10.89 8.16 5.60 6.10 7.12 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 6.79 6.40 3.79 8.30 7.93 Short Term Provisions 14.50 1.01 0.75 8.01 7.89 4.67 8.30 6.95 5.09 5.41 Total Liabilities 329.30 278.26 224.64 202.55 171.39 164.21 148.69 135.78 129.82 142.61 Net Block 85.31 94.45 9.30 24.28 22.60 25.72 24.44 21.64 21.32 21.59 Gross Block 102.00 103.14 11.59 32.87 58.13 60.12 58.17 55.00 53.66 52.88 Accumulated Depreciation 16.69 8.69 2.29 8.59 35.53 34.40 33.74 33.36 32.34 31.28 Non Current Assets 173.59 117.07 27.86 30.39 55.14 43.73 52.39 38.23 35.20 32.50 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 1.90 3.95 3.04 0.00 Non Current Investment 0.00 0.00 0.00 1.12 28.86 12.06 11.39 0.00 0.00 0.00 Long Term Loans & Adv. 3.33 3.90 11.75 0.69 1.07 5.66 14.53 12.63 10.84 10.90 Other Non Current Assets 84.95 18.71 6.81 4.29 2.62 0.29 0.13 0.00 0.00 0.00 Current Assets 155.71 161.19 179.60 172.17 116.25 120.48 96.31 97.56 94.61 110.11 Current Investments 0.00 0.00 0.00 0.00 21.81 3.25 0.00 0.00 0.00 0.00 Inventories 14.64 15.20 15.00 20.68 29.74 29.72 29.32 32.69 51.43 47.62 Sundry Debtors 17.19 13.18 10.95 20.87 15.58 12.66 21.45 20.75 25.15 39.41 Cash & Bank 106.12 128.73 147.93 114.63 25.25 60.23 40.49 38.53 14.51 20.06 Other Current Assets 17.75 1.66 1.60 1.15 23.88 14.61 5.04 5.58 3.51 3.03 Short Term Loans & Adv. 16.09 2.42 4.12 14.85 22.47 14.34 4.52 4.64 3.27 2.80 Net Current Assets 114.79 135.29 160.47 136.99 82.11 80.08 61.74 69.37 66.03 80.68 Total Assets 329.30 278.26 207.46 202.56 171.39 164.21 148.70 135.79 129.81 142.61

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 46.81 55.11 35.17 46.66 6.91 28.22 11.89 30.90 -1.58 -3.24 PBT 57.52 69.86 29.87 34.81 26.64 21.87 9.41 9.00 -11.63 14.40 Adjustment 3.59 -11.94 8.27 9.63 -1.40 -2.09 -0.57 0.33 1.26 -8.63 Changes in Working Capital -2.39 5.34 5.54 9.50 -11.46 11.59 4.84 19.71 8.79 -6.13 Cash after chg. in Working capital 58.71 63.26 43.68 53.93 13.79 31.37 13.69 29.05 -1.58 -0.36 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -11.90 -8.14 -8.51 -7.28 -6.87 -3.15 -1.80 1.85 0.00 -2.88 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -35.65 -45.15 -24.55 -57.67 -25.78 -2.26 -11.07 -0.83 -3.37 41.29 Net Fixed Assets 1.14 -91.55 21.28 25.26 1.99 -0.05 -1.12 -2.25 -3.82 37.47 Net Investments 0.00 0.00 1.12 49.55 -35.36 -3.92 -11.39 0.00 0.00 0.00 Others -36.79 46.40 -46.95 -132.48 7.59 1.71 1.44 1.42 0.45 3.82 Cash from Financing Activity -12.15 -11.70 -8.91 -0.46 -17.55 -6.83 -1.82 -6.05 -0.60 -33.52 Net Cash Inflow / Outflow -0.99 -1.73 1.71 -11.47 -36.42 19.13 -1.01 24.02 -5.55 4.53 Opening Cash & Equivalents 11.03 12.76 11.05 22.53 58.94 39.81 40.82 14.51 20.06 15.53 Closing Cash & Equivalent 10.04 11.03 12.76 11.05 22.53 58.94 39.81 38.53 14.51 20.06

Financial Ratios

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 38.18 32.83 25.77 57.30 50.68 43.55 39.39 36.89 34.43 38.96 ROA 14.18% 22.02% 10.52% 14.29% 11.24% 10.90% 5.53% 5.43% -8.48% 7.86% ROE 18.19% 28.51% 14.02% 18.89% 15.28% 15.70% 7.88% 7.72% -12.01% 12.32% ROCE 22.69% 33.14% 17.72% 24.15% 21.23% 19.43% 9.46% 9.80% -10.52% 14.26% Fixed Asset Turnover 2.97 4.91 10.09 5.65 4.10 3.18 2.80 3.07 2.38 2.03 Receivable days 18.20 15.63 25.88 25.87 21.26 33.13 48.57 50.22 93.07 102.03 Inventory Days 17.89 19.56 29.02 35.78 44.76 57.34 71.38 92.03 142.78 110.02 Payable days 37.27 32.80 55.17 69.43 75.08 67.24 34.46 31.91 27.07 22.17 Cash Conversion Cycle -1.18 2.39 -0.27 -7.78 -9.07 23.23 85.49 110.33 208.78 189.88 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.06 0.06 0.04 0.09 0.08 Interest Cover 56.95 73.92 37.69 85.28 94.48 43.59 19.31 13.08 -16.69 6.44

Top Investors:

manish gupta

investor education and protection fund authority ministry of corporate affairs

authum investment and infrastructure limited

sanjiv kumar dudeja

lincoln p coelho

Annual Reports:

News Update:

Jagsonpal Pharmaceuticals executes BTA to acquire Group Pharma’s wellness portfolio
24th Sep 2026, 14:21 PM

The transaction is expected to be completed on or before November 1, 2026
Read More
Jagsonpal Pharma - Quarterly Results
30th Jul 2026, 00:00 AM

Read More
Jagsonpal Pharmaceuticals completes acquisition of 69.77% stake in Aequitas Healthcare
7th Jul 2026, 16:26 PM

Consequently, Aequitas has become a subsidiary of the Jagsonpal Pharmaceuticals
Read More

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 507789 | NSE: JAGSNPHARM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 507789 | NSE: JAGSNPHARM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: